drugset / Trial / NCT00116584
Heliox-Driven Racemic Epinephrine in Treatment of Bronchiolitis in Pediatric ED Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess whether children with moderate to severe bronchiolitis treated with standard racemic epinephrine therapy via 70:30 helium-oxygen (heliox) driven nebulization will have improvements in measurements of airway more rapidly than those treated with conventional air-oxygen driven nebulization.
Timeline
- Start
- 2004-12
- Primary completion
- 2008-03
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Heliox | Other / unclassified | — | Inhaled |
| Subject | Oxygen | Other / unclassified | — | Inhaled |